Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.

Kwee S, Song MA, Cheng I, Loo L, Tiirikainen M. Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. Clin Transl Sci. 2012 Feb; 5(1):65-70.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Analysis of Variance
Antineoplastic Combined Chemotherapy Protocols
Choline
DNA Methylation
DNA, Neoplasm
Electrophoresis, Microchip
Genetic Markers
Glutathione S-Transferase pi
Hawaii
Humans
Male
Middle Aged
Pilot Projects
Positron-Emission Tomography
Predictive Value of Tests
Promoter Regions, Genetic
Prostatic Neoplasms
Radiopharmaceuticals
Receptors, Retinoic Acid
Taxoids
Tomography, X-Ray Computed
Treatment Outcome
Whole Body Imaging

authors with profiles

Lenora Loo, PhD
Sandi Kwee, MD, PhD
Maarit Tiirikainen, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support